Orphazyme creditors approve restructuring plan
Creditors of embattled biotech company Orphazyme have approved its restructuring plan, the firm announces.
.jpg)
by christopher due karlsson, translated by catherine brett
Last month, Orphazyme started a restructuring process, and creditors have now approved the rescue plan released last week.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Orphazyme down to 20 employees after multiple firing rounds
For subscribers
Orphazyme reveals new release date for 2021 report
For subscribers
.jpg&w=384&q=75)
